Insanity was....Replacing an inexperienced CEO with another inexperienced CEO and then having them split CEO duties... Sheer stupidy; and explains huge valuation discount And now they will not try hard to get big tobacco/pharma partner....why would they?? .....(being the top dog with cushy adoring shareholders who avcept medicre performance)